Skip to main content

Pramana and Techcyte Form Strategic Collaboration to Offer AI-enabled Scanning Technology for Cytology & Microbiology Applications

October 2023

Companies to highlight innovative scanning solutions at Pathology Visions Meeting, Oct. 29-31

CAMBRIDGE, Mass., and OREM, Utah – October 26, 2023Pramana, Inc., an AI-enabled
health tech company modernizing the pathology sector, and Techcyte, a leading developer of
AI-based image analysis solutions for the diagnostics industry, have joined forces to deliver the
first intelligent volumetric scanning and digital diagnostics solution for cytology, microbiology,
and hematology applications. The collaboration will integrate Pramana’s Spectral HT and
Spectral M intelligent whole slide imaging systems with Techcyte’s AI-powered diagnostics
software platform, offering a powerful and transformative solution for lab professionals.

“Our customers are asking for an innovative approach to digitizing and analyzing intricate
microbiology or cytology slides,” said Mike Koenig, Pramana’s Chief Business Development
Officer. “Pramana’s expanded capabilities in these sectors, along with our Techcyte partnership,
represent significant industry milestones. Together, our joint solution will support clinical
diagnoses with novel volumetric scanning technology and AI-powered image analysis, setting
us apart from any other option currently available.”

The multidisciplinary collaboration will include technology development, regulatory compliance,
sales, and global distribution. The integration of Pramana’s scanning technology with Techcyte’s
AI image analysis and workflow software will provide a versatile platform for scalable digitization
of cytology and microbiology diagnostic workflows, including traditionally hard-to-scan

“Pramana’s smart volumetric scanning represents a new technology category that enables
efficient and accurate scanning of challenging sample types,” said Shane Swenson, Techcyte’s
CTO. “The modular system with multiple scanning heads fed by a robotic arm and deeply
integrated image analysis will allow our customers to achieve accuracy, throughput, flexibility,
and redundancy that deliver an attractive return on investment.”

Techcyte’s clinical pathology AI platform harnesses powerful deep machine learning to augment
the work of lab professionals and expand the field of digital diagnostics. This advanced
technology enhances accuracy, streamlines testing workflows, mitigates staffing challenges and
significantly expedites the delivery of diagnoses.

Pramana’s novel approach to whole slide imaging with full-time volumetric scanning enables the
creation of high-fidelity digital captures of glass slides prepared with cytology and microbiology
samples, which are known for having significant and localized variations in the density of
sample material. Pramana’s in-line quality assurance module, with its proprietary algorithm,
enables a high first-pass success rate and eliminates the need for staging the glass slides for
quality control and rescans. Customers can seamlessly use the same scanner for many sample
types, and any special functions for scanning a particular specimen can be triggered through its
built-in Optical Character Recognition (OCR) and Named Entity Recognition (NER) based label
identification software.

Pramana will be featuring its Spectral HT and Spectral M intelligent whole slide imaging
systems at booth #409, and Techcyte will be highlighting its AI software at booth #302 at the
Pathology Visions Annual Meeting in Orlando, Fla., Oct. 29-31.